Author

Kalpana Kalyanasundaram Bhanumathy

University of SaskatchewanORCID 0000-0002-3499-6219Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Approach:deep learning· 1

Frequent Co-Authors

Franco J. VizeacoumariD· 4 shared Frederick S. VizeacoumariD· 3 shared He DongiD· 3 shared Hussain ElhasasnaiD· 3 shared Karthic RajamanickamiD· 3 shared Anand KrishnaniD· 2 shared Andrew FreywaldiD· 2 shared Anil KumariD· 2 shared

Activity by Year

2023-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

Franco J. VizeacoumarORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Microbiologynpj VirusesPeer-reviewedJul 22, 2026

Genome-wide Screening Identifies Unique Host-Directed Drugs and Pro-viral Signalling Pathways for SARS-CoV-2

Juveriya Qamar Khan, Karthic Rajamanickam, Frederick S. Vizeacoumar…·Joyce A. Wilson

This study identifies four host-directed drugs and the NRAS/Raf/MEK/ERK pathway as critical for SARS-CoV-2 replication through CRISPR knockout screens in human lung cells.

DOI 10.1038/s44298-026-00213-5

humangenetic perturbation / CRISPR

𝕏 PostBluesky

Cancer BiologyCell GenomicsPeer-reviewedMay 9, 2025

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality

Chelsea E. Cunningham, Frederick S. Vizeacoumar, Yue Zhang…·Franco J. Vizeacoumar

The paper identifies synthetic dosage lethality targets for PLK1-overexpressing cancers using genome-wide screens and validates key hits to show their therapeutic potential.

8 citations

humanCRISPR screen

𝕏 PostBluesky

Cancer BiologyOncogenePeer-reviewedApr 29, 2025

A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer

Prachi Walke, Jared D. W. Price, Frederick S. Vizeacoumar…·Franco J. Vizeacoumar

This study identifies Neurog2 as a potential therapeutic target for MYCN-driven neuroendocrine prostate cancer by showing its role in promoting tumor growth and NEPC development.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologyVirusesPeer-reviewedMay 30, 2023

Generation of a SARS-CoV-2 reverse genetics system and novel human lung cell lines that exhibit high virus-induced cytopathology

Juveriya Qamar Khan, Megha Rohamare, Karthic Rajamanickam…·Joyce A. Wilson

This paper develops a SARS-CoV-2 reverse genetics system and lung cell lines for studying virus replication, antiviral screening, and host interactions.

10 citations

humanexperimental assay

𝕏 PostBluesky